West Pharmaceutical Services Pre-Tax Income 2010-2024 | WST

West Pharmaceutical Services annual/quarterly pre-tax income history and growth rate from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
  • West Pharmaceutical Services pre-tax income for the quarter ending September 30, 2024 was $0.165B, a 12.03% decline year-over-year.
  • West Pharmaceutical Services pre-tax income for the twelve months ending September 30, 2024 was $0.589B, a 10.58% decline year-over-year.
  • West Pharmaceutical Services annual pre-tax income for 2023 was $0.698B, a 2.66% increase from 2022.
  • West Pharmaceutical Services annual pre-tax income for 2022 was $0.68B, a 9.21% decline from 2021.
  • West Pharmaceutical Services annual pre-tax income for 2021 was $0.749B, a 86.62% increase from 2020.
West Pharmaceutical Services Annual Pre-Tax Income
(Millions of US $)
2023 $698
2022 $680
2021 $749
2020 $401
2019 $292
2018 $241
2017 $222
2016 $190
2015 $116
2014 $169
2013 $147
2012 $109
2011 $93
2010 $75
2009 $83
West Pharmaceutical Services Quarterly Pre-Tax Income
(Millions of US $)
2024-09-30 $165
2024-06-30 $129
2024-03-31 $127
2023-12-31 $168
2023-09-30 $187
2023-06-30 $185
2023-03-31 $158
2022-12-31 $129
2022-09-30 $136
2022-06-30 $227
2022-03-31 $188
2021-12-31 $182
2021-09-30 $181
2021-06-30 $211
2021-03-31 $175
2020-12-31 $115
2020-09-30 $98
2020-06-30 $102
2020-03-31 $87
2019-12-31 $77
2019-09-30 $65
2019-06-30 $80
2019-03-31 $70
2018-12-31 $66
2018-09-30 $61
2018-06-30 $60
2018-03-31 $54
2017-12-31 $59
2017-09-30 $63
2017-06-30 $41
2017-03-31 $60
2016-12-31 $53
2016-09-30 $49
2016-06-30 $60
2016-03-31 $28
2015-12-31 $43
2015-09-30 $-7
2015-06-30 $36
2015-03-31 $44
2014-12-31 $42
2014-09-30 $41
2014-06-30 $50
2014-03-31 $36
2013-12-31 $34
2013-09-30 $36
2013-06-30 $39
2013-03-31 $39
2012-12-31 $28
2012-09-30 $22
2012-06-30 $20
2012-03-31 $38
2011-12-31 $23
2011-09-30 $22
2011-06-30 $24
2011-03-31 $24
2010-12-31 $2
2010-09-30 $21
2010-06-30 $27
2010-03-31 $25
2009-12-31 $18
2009-09-30 $22
2009-06-30 $25
2009-03-31 $18
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.024B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36